CCD Module 10
CCD Module 10
diabetic persons
surgery of
points regarding
Steps Actions
1. Pre operative assessment
2. Actions of Day prior to Surgery
3. Actions of Day of Surgery
4. Actions of During operation
5. Post-operative care
General principles of management
( Step 1 & 2)
Step 1. Pre-operative assessment for Surgery for person with DM
1. Pre-operative assessment must be done in close consultation with the physician, surgeon and
anesthetist
2. It should include assessment of any diabetic complications or associated conditions, which may
increase surgical risk, e.g. cardiac autonomic neuropathy.
Frequent tests for blood glucose & Sufficient intake is necessary to The anti-diabetic agents should
ketone in urine maintain fluid balance. not be stopped altogether;
Dose of insulin / secretaguges may
If the blood glucose is low, need to be reduced.
sweetened fluids, e.g. fruit juice is Longer acting secretaguges may
to be given to avoid hypoglycaemia. need to be replaced by shorter
If blood glucose is elevated, low acting ones or insulin.
calorie soft drinks, soup or broth In case of vomiting or diarrhoea
may be given. metformin/ alfa-glucosidase
inhibitors is withdrawn temporarily
Some key points on Sick days’ management
Severity of the risk in an individual i.e. categorization depends on factors namely diabetic
control, treatment regimen and co-existing disease.
Categories of risk in DM for Ramadan
Risk categories Features
Severe hypoglycemia within the last 3 months prior to Ramadan
Patient with history of recurrent hypoglycemia
Patient with hypoglycemia unawareness
Patient with sustained poor glycemic control
Ketosis within the last 3 months prior to Ramadan
Very high risk group Type 1 DM
Acute illness
Hyperosmolar hyperglycemic coma within the last 3 months
Patients who performs intense physical labour
Pregnancy
Patient on dialysis
Patient with moderate hyperglycemia (average blood glucose between 150 and 300 mg/dl, HbA1c 7.5-9.0%)
Patients with renal insufficiency
Patients with advanced macrovascular complications
High risk group People living alone who are treated with insulin or sulphonylureas
Patients with comorbid conditions that presents additional risk factors.
Old age with ill health
Drugs that may affect mentation
Moderate risk group Well controlled patients treated with short acting secretagogues such as repaglinide or nateglinide
Low risk group Well-controlled patients treated with diet alone, metformin or a thiazolidinedione who are otherwise healthy.
Management of diabetes during fasting should consist of pre-Ramadan medical assessment and educational
counseling. Persons eligible for fasting needs appropriate modification in diet and drugs, and monitoring of
blood glucose on regular basis,
General considerations
Frequent monitoring of glycemic status: Two important times are 2 hours after sehri and 1 hour prior to ifter.
Testing at other times may also be done.
Nutrition: In terms of calorie and composition, diet should remain same healthy and balanced as before Ramadan.
Ingestion of large amount of foods rich in carbohydrate and fats during ifter should be avoided. A complex
carbohydrate that is slow in digestion and absorption is good choice for sehri, while food with more simple
carbohydrate may be taken during ifter. Sehri (pre-dawn meal) should be taken as late as possible.
Exercise: Normal level of activity is recommended. Excessive physical activities may lead to hypoglycemia.
Tarawih prayer can be considered as part of daily exercise program. Exercise between ifter and dinner may be
undertaken.
Breaking the fasting: If blood sugar goes <3.3 mmol/L (60 mg/dl) at any time, or <3.9 mmol/L (70 mg/dl) during
first few hours of sehri, or > 16.7 mmol/L (300 mg/dl), and on sick days.
Medical assessment: Glycemic status, BP and lipid profile are to be stabilized before Ramadan.
Blood glucose must be checked after first few days of fasting to readjust the doses of the medications.
Management of diabetes during Ramadan
Specific measures
Type2 DM
Patients on diet control only - risk during fasting is low.
Patients on oral agents:
Risk of fasting hypoglycemia is low if on insulin sensitizers or DPP-4 inhibitors or GLP-1 agonists; but risk increases when secretagogues (specially longer
acting) are used.
Biguanide- needs some dose adjustment.
Glitazone, DPP-4 inhibitors and GLP-1 agonists, alpha glucosides inhibitors - need no dose change.
Secretagogues-glimepiride/glicazide-MR/glinides are preferred preparations; sulphonyl- ureas need some dose adjustment; glinides need no dose change.
Patients on insulin - dose readjustment is to be made according to the type of insulin.
Patients on once-daily-drug-regimen (OAD or insulin) - the usual dose of antidiabetic agent can be taken at sun-set; sometimes the dose may need to be
reduced.
Patients on twice-daily-drug-regimen (OAD or insulin) -the usual morning dose of anti-diabetic agent is taken at sun-set; the evening dose is reduced to 50%
and taken at dawn.
Patients on thrice-daily-drug-regimen (OAD or insulin):
o The total dose of metformin is divided into two-thirds to be taken at sun set, and one-third at dawn.
o In case of rapid acting insulin or glinides the usual dose can be taken with meals.
o Short acting insulin is to be taken twice daily with larger share at sun-set.
Patients on basal -bolus (4 times) insulin regimen - long acting insulin may be taken at sunset in reduced dose with rapid acting ones 2-3 times with meals (may
be in reduced dose).
Management of diabetes during Ramadan
Specific measures
Type1 DM
Some experienced physicians conclude that Ramadan fasting is safe for typel patients with proper self-
monitoring of blood glucose and close supervision. Two insulin regimens have been studied successfully.
Three-dose insulin regimen - two doses before meals (sunset and dawn) of short acting insulin and one dose
in the late evening of intermediate-acting insulin.
Two-dose insulin regimen - evening insulin of combined short-acting and intermediate-acting insulin
equivalent to the previous morning dosage, and a predawn insulin consisting only of short-acting insulin.
Prevention of DM
Diabetes mellitus, a chronic debilitating disease, is associated with a range of severe complications.
Prevention of diabetes is feasible and is evident in many studies done in various countries.
Prevention means preventing or delaying diabetes as well as the complications both in terms of
beginning and progression.
The prevention is done by modifying the modifiable risk factors.
Types of DM Prevention
Primary prevention Secondary prevention Tertiary prevention
aims to delay and/or
means early detection of diabetes
prevent further
refers to avoiding the onset and prompt initiation of treatment
progression of the
of the disease (diabetes) to prevent complications of
diabetic
diabetes.
complications.
Primary prevention of DM
• Population • High-risk
approach group
approach
1 2
Approach to Prevention of DM
Measurement of risk
Risk factor of DM
Modifiable risk Non modifiable risk
2 2
BMI above normal (>25 kg/m ; for the Asians >23 kg/m ) Age > 40 years
Habitual physical inactivity Positive family history of DM
Waist-hip ratio above normal( >0.9 for male; > 0.8 for female) Previously identified as IFG/IGT
Hypertension History of GDM or delivery of baby >9 1bs
Dyslipidemia Infertility, pregnancy loss
PCOS, acanthosisnigricans etc. Some ethnicities- asians
Prevention of DM
Intervention
It is done by ensuring weight management, regular physical activity, medical nutrition
therapy and even by using drugs (like metformin) to modify the risk factors.
Risks of type2 DM in Asian countries
Bangladesh and other Asian countries are at higher risk of type2 diabetes and its complications because:
Risk of type2 DM starts at lower BMI
More prone to abdominal obesity, low muscle mass and insulin resistance
Higher visceral or subcutaneous fat despite lower waist circumference or BMI
Urbanization-rapid nutritional transition, reduced physical activity, mental stress
Increase in smoking
Intra-uterine or early childhood malnutrition
Increased prevalence of GDM, risking mother and baby
Chronic arsenic exposure
Genetic susceptibility
Earlier age of onset of DM
More vulnerable to some complications, e.g. CAD, stroke, nephropathy, some malignancies and all cause
mortality. Therefore, countries of this region should adopt their national policy to prevent diabetes mellitus.
Primary prevention of type1 DM
• For type1 diabetes genetic and immunological markers are available but these are costly.
• It is not feasible to use them for population-based identification, but specific high-risk
groups can be screened. The cost effectiveness, and social and moral issues of such
screening activities remain unclear.
• Some suggested strategies include encouraging breast-feeding, use of antioxidants and
beta cell rest by giving insulin to individuals with identified genetic and immunological
markers.
• As yet there is no evidence to suggest that type1 diabetes can be prevented, but none-the-
less efforts continue, as it is a goal worth pursuing.
Secondary prevention of DM
Fasting/pre-meal <6.0 mmol/L
Post-meal <8.0 mmol/L
HbAlc <7%
LDL cholesterol <100mg/dl
Blood lipids HDL cholesterol >40 mg/dl (male) &>50 mg/dl (female)
Triglyceride <1 50 mg/dl
Target of blood pressure
Systolic <140mmofHg
BP
Diastolic <80mmofHg
Target of body weight & obesity
BMI* <25 kg/m2
BMI& Waist circumference (WC)
WC <90 cm (male) & <80 cm (female)
Teaching, training & empowerment to take part in
Target of diabetic education treatment
Tertiary prevention of DM
• Tertiary prevention
• Interventions designed to minimize consequences of diabetes and help rehabilitation fall under
this category. Here attempts are directed to contain damage by aggressive therapy to arrest or
delay progression of complications. Each complication may be addressed with special objectives
and strategies reducing morbidity and mortality.
• Screening for complications
• Type1 DM
• At or after 5 years of diagnosis (or earlier); then every year (in absence of complications)
• Type2 DM
• At diagnosis; then every year (in absence of complications)
Effective strategies of tertiary prevention
Prevention of Prevention of
lower limb cardiovascular
amputation disease
Effective strategies of tertiary prevention
• Control of • Control of
hypertension hypertension
• (When necessary) • Laser
low protein diet photocoagulation
• Control of • Control of
hyperglycemia, etc. hyperglycemia, etc.
Prevention of Prevention
renal disease of blindness
Prevention of DM
• Diabetic complications account for 60% of diabetes related health care costs (direct costs) and
almost 80-90% of indirect costs. Preventing complications is therefore not only beneficial to
individuals but also to the society as a whole. Economic analysis from the different studies has
shown that prevention programmes are cost effective. Other studies also have shown that
simple measures, like education and awareness also help.
•
• Comprehensive care of diabetes with patient education and awareness about complications can
bring about a remarkable reduction in blindness, end-stage renal diseases (ESRD), lower
extremity amputation and cardiovascular events.
•
Stay home and Stay Safe